{
    "paper_id": "738632",
    "score": 4,
    "summary": "In this context, nitric oxide is highlighted as a potential screening agent for identifying patients with primary pulmonary hypertension who may respond positively to calcium-channel blockers. The study suggests that nitric oxide could help determine which patients are likely to benefit from long-term treatment with these medications, indicating a significant relationship between nitric oxide and primary pulmonary hypertension management."
}